Showing items 1 - 3 of 3

Your selections:

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

- Siva, Shankar, Bressel, Mathias, Lin, Charles, Raman, Avi, Hardcastle, Nicholas, Hofman, Michael S., De Abreu Lourenco, Richard, Shaw, Mark, Mancuso, Pascal, Moon, Daniel, Wong, Lih-Ming, Lawrentschuk, Nathan, Sidhom, Mark, Wood, S, Brook, NR, Kron, T, Martin, Jarad, Pryor, D, FASTRACK II Investigator Group,, Sridharan, Swetha, Vanneste, Ben G. L., Davey, Ryan, Montgomery, Rebecca, Ruben, Jeremy, Foroudi, Farshad, Higgs, Braden

Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial

- Hardcastle, Nicholas, Kron, Tomas, Cook, Olivia, Lehmann, Joerg, Mitchell, Paul L. R., Siva, Shankar

Geometric uncertainty analysis of MLC tracking for lung SABR

- Caillet, Vincent, Zwan, Benjamin, Briggs, Adam, Hardcastle, Nicholas, Szymura, Kathryn, Prodreka, Alexander, O'Brien, Ricky, Harris, Ben E., Greer, Peter, Haddad, Carol, Jayamanne, Dasantha, Eade, Thomas, Booth, Jeremy, Keall, Paul

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit